Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06726941 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Exercise Gene Expression and Histone Modifications in Patients With Hemiplegia

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed Show 5 more changesShow less
    • Primary completion date changed from estimate of Jun 9, 2026 to Sep 9, 2026
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 7 of 7 entries
    • Site details revised
    • Publications: details revised at 3 of 3 entries
  2. Minor Eligibility criteria revisedv4
  3. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 1, 2025 to Dec 20, 2024
    • Secondary endpoints revised (7)
    • Study description expanded, about 2 words
  4. Notable Primary endpoints: 2 to 3v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study is to demonstrate the effect of routine exercise program on neuroplasticity through histone acetylation and gene expression changes in acute stroke survivors from an epigenetic perspective and to investigate the correlation of epigenetic effects with its effects on motor function and quality of life.
Trial Details
NCT Number NCT06726941
Lead Sponsor Afyonkarahisar Health Sciences University
Conditions
(from sponsor)
Ischemic Stroke, Acute, Acute Hemiparesis
Related terms Ischemic Stroke
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov